NCT02623777View on ClinicalTrials.gov

Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Arabinoxylan oligosaccharides

Arabinoxylan oligosaccharides administered

DIETARY_SUPPLEMENT

Short chain fatty acids

Short chain fatty acids administered

All Listed Sponsors
lead

KU Leuven

OTHER

NCT02623777 - Effect of Arabinoxylan Oligosaccharides Consumption on Insulin Resistance in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter